In the past decades, quotation theories have developed roughly along three lines-quotation types, meaning effects, and theoretical orientations toward the semantics/pragmatics distinction. Currently, whether the quoted expression is truth-conditionally relevant to the quotational sentence, and if there is a truth-conditional impact, whether it is generated via semantic or pragmatic processes, have become the central concerns of quotation studies. In this book, quotation is clearly defined for the first time as a constituent embedded within yet distinctive from the quotational sentence. Also, as the first monograph to address the semantics/pragmatics boundary dispute over quotation, it argues that the semantic content of quotation amounts to its contribution to the intuitive truth-conditional content of the quotational utterance via two modes of presentation, which are incarnated in the functioning of quotation marks and manifested as use and mention. The use/mention-based analysis in this book can shed light on the semantic theorizing of other metalinguistic phenomena, while the semantics/pragmatics perspective will provide methodological implications for other relevant studies. The new conception of quotation and thought-provoking analysis on use/mention, truth-conditional pragmatics, and the semantics/pragmatics boundary in this book will appeal to scholars and students in philosophy of language and linguistics. It will also serve as a clear guide to the current state of quotation studies and how to formulate a semantic theory of quotation.

Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis provides statisticians with an understanding of the critical challenges currently encountered in oncology trials. Well-known statisticians from academic institutions, regulatory and government agencies (such as the U.S. FDA and National Cancer Institute), and the pharmaceutical industry share their extensive experiences in cancer clinical trials and present examples taken from actual trials. The book covers topics that are often perplexing and sometimes controversial in cancer clinical trials. Most of the issues addressed are also important for clinical trials in other settings. After discussing general topics, the book focuses on aspects of early and late phase clinical trials. It also explores personalized medicine, including biomarker-based clinical trials, adaptive clinical trial designs, and dynamic treatment regimes.

In the past decades, quotation theories have developed roughly along three lines-quotation types, meaning effects, and theoretical orientations toward the semantics/pragmatics distinction. Currently, whether the quoted expression is truth-conditionally relevant to the quotational sentence, and if there is a truth-conditional impact, whether it is generated via semantic or pragmatic processes, have become the central concerns of quotation studies. In this book, quotation is clearly defined for the first time as a constituent embedded within yet distinctive from the quotational sentence. Also, as the first monograph to address the semantics/pragmatics boundary dispute over quotation, it argues that the semantic content of quotation amounts to its contribution to the intuitive truth-conditional content of the quotational utterance via two modes of presentation, which are incarnated in the functioning of quotation marks and manifested as use and mention. The use/mention-based analysis in this book can shed light on the semantic theorizing of other metalinguistic phenomena, while the semantics/pragmatics perspective will provide methodological implications for other relevant studies. The new conception of quotation and thought-provoking analysis on use/mention, truth-conditional pragmatics, and the semantics/pragmatics boundary in this book will appeal to scholars and students in philosophy of language and linguistics. It will also serve as a clear guide to the current state of quotation studies and how to formulate a semantic theory of quotation.

This book ambitiously presents the current directions and goals of the Chinese idea of modernization in education. Searching for a neutral way to understand educational reform and policy-making in the midst of many different theories in the field, the authors combine the theories of ecology, regional studies, and educational philosophy to focus on the hot topics relating to the current problems in Chinese education. In addition to the theory of education, it offers an interdisciplinary approach to educational policy and administration, including perspectives from history, evaluation and (big) data processing, modernization, planning-making, curriculum and teaching, element analysis etc. within or beyond the limits of education. This book is a valuable resource for policy-makers and administrators as well as teachers and students majoring in education or related fields. It is also beneficial to those interested in interdisciplinary approaches to educational theory studies and regional studies in education, and practitioners in schools and higher education institutes as well as anyone wanting insights into Chinese education from the perspective of regional studies.

This book constitutes the proceedings of the Third International Conference on 6G for Future Wireless Networks, 6GN 2020, held in Tianjin, China, in August 2020. The conference was held virtually due to the COVID-19 pandemic. The 45 full papers were selected from 109 submissions and present the state of the art and practical applications of 6G technologies. The papers are arranged thematically on network scheduling and optimization; wireless system and platform; intelligent applications; network performance evaluation; cyber security and privacy; technologies for private 5G/6G.

This book ambitiously presents the current directions and goals of the Chinese idea of modernization in education. Searching for a neutral way to understand educational reform and policy-making in the midst of many different theories in the field, the authors combine the theories of ecology, regional studies, and educational philosophy to focus on the hot topics relating to the current problems in Chinese education. In addition to the theory of education, it offers an interdisciplinary approach to educational policy and administration, including perspectives from history, evaluation and (big) data processing, modernization, planning-making, curriculum and teaching, element analysis etc. within or beyond the limits of education. This book is a valuable resource for policy-makers and administrators as well as teachers and students majoring in education or related fields. It is also beneficial to those interested in interdisciplinary approaches to educational theory studies and regional studies in education, and practitioners in schools and higher education institutes as well as anyone wanting insights into Chinese education from the perspective of regional studies.

This book constitutes the refereed proceedings of the 11th China Conference on Wireless Sensor Networks, CWSN 2017, held in Tianjin, China, in October 2017. The 28 revised full papers were carefully reviewed and selected from 213 submissions. The papers are organized in topical sections on wireless sensor networks; energy efficiency and harvesting; data fusion; mobile computing and social services.

Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis provides statisticians with an understanding of the critical challenges currently encountered in oncology trials. Well-known statisticians from academic institutions, regulatory and government agencies (such as the U.S. FDA and National Cancer Institute), and the pharmaceutical industry share their extensive experiences in cancer clinical trials and present examples taken from actual trials. The book covers topics that are often perplexing and sometimes controversial in cancer clinical trials. Most of the issues addressed are also important for clinical trials in other settings. After discussing general topics, the book focuses on aspects of early and late phase clinical trials. It also explores personalized medicine, including biomarker-based clinical trials, adaptive clinical trial designs, and dynamic treatment regimes.